EP1797883A3 - Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid - Google Patents

Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid Download PDF

Info

Publication number
EP1797883A3
EP1797883A3 EP07104359A EP07104359A EP1797883A3 EP 1797883 A3 EP1797883 A3 EP 1797883A3 EP 07104359 A EP07104359 A EP 07104359A EP 07104359 A EP07104359 A EP 07104359A EP 1797883 A3 EP1797883 A3 EP 1797883A3
Authority
EP
European Patent Office
Prior art keywords
cathepsin
opioid
inhibitor
pain
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07104359A
Other languages
German (de)
French (fr)
Other versions
EP1797883A2 (en
Inventor
Pamposh Ganju
Marzia Malcangio
Chuanzheng Song
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Pharma GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH, Novartis AG filed Critical Novartis Pharma GmbH
Priority claimed from EP04729640A external-priority patent/EP1620106A1/en
Publication of EP1797883A2 publication Critical patent/EP1797883A2/en
Publication of EP1797883A3 publication Critical patent/EP1797883A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The present invention relates to combinations suitable for the treatment of pain of various genesis or aetiology comprising a cathepsin S inhibitor and an opioid, for simultaneous, separate or sequent ial use, to a method of treating or ameliorating pain in a warm-blooded animal in need thereof, to the use of a combination as specified above for the preparation of a medicament for the treatment of pain and to pharmaceutical compositions and commercial packages comprising such combinations.
EP07104359A 2003-04-28 2004-04-27 Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid Withdrawn EP1797883A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46611603P 2003-04-28 2003-04-28
EP04729640A EP1620106A1 (en) 2003-04-28 2004-04-27 Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP04729640A Division EP1620106A1 (en) 2003-04-28 2004-04-27 Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid

Publications (2)

Publication Number Publication Date
EP1797883A2 EP1797883A2 (en) 2007-06-20
EP1797883A3 true EP1797883A3 (en) 2007-08-01

Family

ID=38039124

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07104359A Withdrawn EP1797883A3 (en) 2003-04-28 2004-04-27 Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid

Country Status (1)

Country Link
EP (1) EP1797883A3 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020721A1 (en) * 2001-08-30 2003-03-13 Novartis Ag Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
WO2003020287A2 (en) * 2001-08-30 2003-03-13 Novartis Ag Methods for the treatment of chronic pain anc compositions therefor
WO2004069256A1 (en) * 2003-02-06 2004-08-19 Novartis Ag 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020721A1 (en) * 2001-08-30 2003-03-13 Novartis Ag Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
WO2003020287A2 (en) * 2001-08-30 2003-03-13 Novartis Ag Methods for the treatment of chronic pain anc compositions therefor
WO2004069256A1 (en) * 2003-02-06 2004-08-19 Novartis Ag 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof

Also Published As

Publication number Publication date
EP1797883A2 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
MY143795A (en) Tetrahydropyridoindole derivatives
WO2004006858A3 (en) Compounds, compositions, and methods employing same
EP2698167A3 (en) Dosage form of an estriol and glatiramer acetate polymer-1 for the treatment of multiple sclerosis
IL157656A (en) Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes
HUP0401192A3 (en) Use of photosenzitizing agent for preparation ot, of pharmaceutical composition for treating wounds
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
IL173348A (en) Thienopyridine compounds, pharmaceutical compositions comprising same and use thereof in the preparation of medicaments
EP2540301A3 (en) Methods and pharmaceutical compositions for healing wounds
EP2281561A3 (en) Use of LCK inhibitors for treatment of immunologic diseases
WO2004103297A3 (en) Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
WO2005034883A3 (en) A method of healing skin wounds in mammals and a composition therefor
IL173148A0 (en) Methods and pharmaceutical compositions for healing wounds
WO2001097793A3 (en) 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
EP3305305A3 (en) Silicate containing compositions and methods of treatment
CA2412789A1 (en) Compositions for improving mental concentration
WO2006021401A3 (en) Bicylononene derivatives
HK1092693A1 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
WO2003007876A3 (en) N-fatty acid-amino acid conjugates and therapeutic uses
EP1797883A3 (en) Pharmaceutical composition comprising a cathepsin S inhibitor and an opioid
MXPA05011593A (en) Pharmaceutical compositon comprising a cathepsin s inhibitor and an opioid.
HUP0301451A3 (en) Use of cgmp pde5 inhibitors for the preparation of pharmaceutical compositions treating peripheral vascular diseases, peripheral neuropathies and autonomic neuropathies
WO2008060535A3 (en) Use of reversine and analogs for treatment of cancer
WO2008059009A3 (en) Factor v mutants for hemostasis in hemophilia
BR0113886A (en) Composition, pharmaceutical composition, combination treatment for preventing or inhibiting thrombin generation or activity in a patient, method for inhibiting or preventing thrombin generation or activity in a patient, use of a composition or combination treatment, use of a composition, use and kit

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 1620106

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

17P Request for examination filed

Effective date: 20080201

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS AG

Owner name: NOVARTIS PHARMA GMBH

17Q First examination report despatched

Effective date: 20080312

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080923